Steven Quay, a biopharmaceutical executive with no background in infectious diseases, is no longer being considered for ...

Parkinson’s disease cell therapy-focused Aspen Neuroscience and bispecific biotech Bambusa Therapeutics are the latest drug ...

WASHINGTON, Oct. 9, 2026 / Pulmo Balance today released a September brand-protection review and an independent laboratory review of lot PULM-2609-41, reporting 902 unauthorized listings carrying its ...

WASHINGTON, Oct. 9, 2026 / Breathizen today released a September brand-protection review showing 553 unauthorized listings carrying its name, 395 of them removed or suspended by Sept. 30, after 843 of ...

Indian industry must accelerate innovation to achieve 2047 objectives: Dr Jitendra Singh ...

A Central Mass. school's proposed building project aims to expand career and technical education by converting existing programs into state-certified Chapter 74 vocational offerings, pending approval.

Welcome back to Endpoints Weekly! We unveiled our 2026 Women in Biopharma special project on Monday. Our team pored through nearly 200 nominations to reach this year’s list of 20 ...

Her grandson, Ron Lacks, says the estate remains excluded from some decisions, even as other descendants work with Johns Hopkins ...

Researchers at the University of Alaska Fairbanks are working to turn coal waste into a source of critical minerals, using microorganisms and artificial intelligence as part of a $6 million National ...

Scientists have a well-established animal model to study Fragile X: the Fragile X knockout mouse. These mice exhibit several ...

Built from a patient’s own cells, the technology is advancing toward its first human trial at Sheba Medical Center in 2027, ...

Clareo Biosciences co-founder Melissa Smith explains why Kentucky is emerging as a destination for biotech and life sciences startups.